Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide

Blood

Volumn 88, Issue 9, 1996, Pages 3522-3527

  Ten Bosch, George J A ^a   Joosten, Antonia M ^a   Kessler, Jan H ^a   Melief, Cornelis J M ^a   Leeksma, Onno C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ANTIGEN PRESENTING CELL; ARTICLE; BLAST CELL; BLAST CELL CRISIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0029967001     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3522.bloodjournal8893522     Document Type: Article

References (33)

1. Bernards A, Rubin CM, Westbrook CA, Paskind M, Baltimore D: The first intron of the human c-abl is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol 7:3231, 1987
2. Heisterkamp N, Stam K, Groffen J, De Klein A, Grosveld G: Structural organisation of the bcr gene and its role in the Ph' translocation. Nature 315:758, 1985
3. Grosveld G, Verwoerd T, Van Agthove T, De Klein A, Ramachandran KL, Stam K, Groffen J: The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr-c-abl transcript. Moll Cell Biol 6:607, 1986
4. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550, 1985
5. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the BCR-ABL fused gene. Cell 47:277, 1986
6. Melo JV, Gordon DE, Cross NCP, Goldman JM: The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81:158, 1993
7. Lee MS, LeMaistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA: Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood 73:2165, 1989
8. Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y, Matsuyama K, Hirabayashi N, Yamada H, Naito K, Imai K, Sakamaki H, Asai O, Mitzutani S: Long persistent BCR-ABL positive transcript detected by polymerase chain reaction after bone marrow transplantation for chronic myelogenous leukemia without clinical relapse: A study of 64 patients. Blood 81:1089, 1993
9. Lange W, Snyder DS, Castro R, Rossi JJ, Blume KG: Detection by enzymatic amplification of BCR-ABL MRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. Blood 73:1735, 1989
10. Hughes T, Morgan GJ, Martiat P, Goldman JM: Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
11. Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D: Prognostic significance of Philadelphia chromosome positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 79:276, 1992
12. Saglio G, Pane F, Gottardi E, Frigeri F, Buonaiuto MR, Guerrasio A, De Micheli D, Parziale A, Fornaci MN, Martinelli G, Salvatore F: Consistent amounts of acute leukemia-associated p190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87:1075, 1996
13. van Rhee F, Hochhaus A, Lin F, Melo JV, Cross NC, Goldman JM: P190 BCR-ABL mRNA is frequently expressed at a low level in p210 CML and p210 ALL. Blood 86:745a, 1995 (abstr)
14. Konopka JB, Witte ON: Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 5:3116, 1985
15. bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
16. Voncken JW, Morris C, Pattengale P, Dennert G, Kikly C, Groffen J, Heisterkamp N: Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice. Blood 79:1029, 1992
17. Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H: Expression of p210bcr/abl by metallothionein promotor induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
18. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N: BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood 86:4603, 1995
19. BCR-ABL protein. Proc Natl Acad Sci USA 89:1468, 1992
20. BCR-ABL by human T cells. Leukemia 9:1344, 1995
21. Heisterkamp N, Stam K, Groffen J, De Klein A, Grosveld G: Structural organization of the bcr gene and its role in the Ph' translocation. Nature 73:1038, 1989
22. Gausepohl H, Kraft M, Boulin C, Frank RW: Automated multiple peptide synthesis. Pept Res 5:315, 1992
23. Maurer J, Thiel E: PCR-Based rapid detection of the Philadelphia-chromosome in chronic myelogenous and acute lymphoblastic leukemia, in Rolfs A, Schumacher HC, Marx P (eds): PCR Topics. Berlin, Germany, Springer-Verlag, 1991, p 234
24. Rebai N, Malissen B: structural and genetic analysis of HLA class I molecules using monoclonal antibodies. Tissue Antigens 22:107, 1983
25. Ottenhof THM, Mutis T: Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones: A potentially immunoregulatory T-T cell interaction in man. J Exp Med 171:2011, 1990
26. Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R: Subcellular localization of BCR, ABL and BCR-ABL proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 92:1925, 1993
27. Melief CJM, Kast WM: Potential immunogenicity of oncogene and tumor suppressor gene products. Curr Opin Immunol 5:709, 1993
28. Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A: Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 85:2680, 1995
29. Rosenzwajg M, Canque B, Gluckman JC: Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 87:535, 1996
30. Wucherpfennig KW, Strominger J: Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695, 1995
31. Anderson DC, van Schooten WC, Barry ME, Janson AA, Buchanan TM, de Vries RRP: A mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science 242:259, 1988
32. Biernaux C, Loos M, Sels A, Huez G, Strykmans P: Detection of bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
33. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA: Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87:3587, 1996